Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA May Bring Legal Action Against States, Cities To Resolve Rx Importation

This article was originally published in The Pink Sheet Daily

Executive Summary

While enforcement efforts have focused on commercial importation, FDA's Hubbard says the agency may eventually "be forced to sue a state or city." Boston recently launched a program where it will cover patients' copays and shipping charges.

You may also be interested in...



Rx Depot Signs Consent Decree Admitting Liability For Importation

The firm and its corporate officers agree to permanently cease operations involving the illegal importation of prescription drugs. Rx Depot has been under a preliminary injunction since November 2003.

Rx Depot Signs Consent Decree Admitting Liability For Importation

The firm and its corporate officers agree to permanently cease operations involving the illegal importation of prescription drugs. Rx Depot has been under a preliminary injunction since November 2003.

Rx Imports From Canada Reimbursed By Minnesota Health Plan

HealthPartners is reimbursing beneficiaries for Canadian purchases, but not at the point of sale. Minnesota has asked HealthPartners to add Canadian pharmacies to its retail network and to accept electronic claims for drugs purchased abroad, but the health plan accepts only paper claims.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel